DK3456340T3 - Glp-1-receptorantagonist til brug ved behandling af medfødt hyperinsulisme - Google Patents
Glp-1-receptorantagonist til brug ved behandling af medfødt hyperinsulisme Download PDFInfo
- Publication number
- DK3456340T3 DK3456340T3 DK18201976.0T DK18201976T DK3456340T3 DK 3456340 T3 DK3456340 T3 DK 3456340T3 DK 18201976 T DK18201976 T DK 18201976T DK 3456340 T3 DK3456340 T3 DK 3456340T3
- Authority
- DK
- Denmark
- Prior art keywords
- hyperinsulism
- glp
- congenital
- treatment
- receptor antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87903307P | 2007-01-08 | 2007-01-08 | |
| EP14171762.9A EP2818181B1 (en) | 2007-01-08 | 2008-01-08 | Compositions and medical uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3456340T3 true DK3456340T3 (da) | 2022-03-21 |
Family
ID=39609282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18201976.0T DK3456340T3 (da) | 2007-01-08 | 2008-01-08 | Glp-1-receptorantagonist til brug ved behandling af medfødt hyperinsulisme |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US9821031B2 (da) |
| EP (4) | EP2120994B1 (da) |
| CY (1) | CY1125273T1 (da) |
| DK (1) | DK3456340T3 (da) |
| ES (3) | ES2908838T3 (da) |
| HR (1) | HRP20220346T3 (da) |
| HU (1) | HUE058307T2 (da) |
| LT (1) | LT3456340T (da) |
| PL (1) | PL3456340T3 (da) |
| PT (1) | PT3456340T (da) |
| SI (1) | SI3456340T1 (da) |
| TR (1) | TR201900959T4 (da) |
| WO (1) | WO2008085982A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20220346T3 (hr) | 2007-01-08 | 2022-09-02 | The Trustees Of The University Of Pennsylvania | Antagonist glp-1 receptora za upotrebu u liječenju kongenitalnog hiperinzulinizma |
| CA2875983A1 (en) * | 2012-02-08 | 2013-08-15 | Seneb Biosciences, Inc. | Treatment of hypoglycemia |
| CN106232627A (zh) * | 2014-02-21 | 2016-12-14 | 免疫医疗有限责任公司 | 抗pcsk9～glp‑1融合体及其使用方法 |
| EP3265491A1 (en) | 2015-03-03 | 2018-01-10 | Xoma (Us) Llc | Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery |
| ES2887723T3 (es) * | 2015-05-22 | 2021-12-27 | Univ Leland Stanford Junior | Tratamiento de hipoglucemia posbariátrica con exendina(9-39) |
| US10653753B2 (en) | 2016-03-04 | 2020-05-19 | Eiger Biopharmaceuticals, Inc. | Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives |
| BR112019010236A2 (pt) * | 2016-11-21 | 2019-08-20 | Eiger Biopharmaceuticals Inc | formulações tamponadas de exendina (9-39) |
| CN116606367A (zh) * | 2022-05-31 | 2023-08-18 | 南京盛德瑞尔医药科技有限公司 | 长效Exendin-9-39及其在低血糖治疗中的应用和作为治疗低血糖的药物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5424286A (en) * | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
| US20040092443A1 (en) * | 1996-08-06 | 2004-05-13 | Yeda Research And Development Co., Ltd | Long-acting exendins and exendin agonists |
| US6469021B1 (en) * | 1998-12-10 | 2002-10-22 | Agouron Pharmaceuticals, Inc. | Non-peptide antagonists of GLP-1 receptor and methods of use |
| US6903074B1 (en) | 1999-06-04 | 2005-06-07 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Neuromedin b and somatostatin receptor agonists |
| SE0004462D0 (sv) * | 2000-12-04 | 2000-12-04 | Pharmacia Ab | Novel method and use |
| WO2002066062A2 (en) * | 2001-02-01 | 2002-08-29 | Drucker Daniel J | Enhancement of glp-2 activity |
| JP4398644B2 (ja) | 2001-04-06 | 2010-01-13 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルベニア | ＥｒｂＢ界面ペプチド擬態およびその使用方法 |
| CN1162446C (zh) * | 2001-05-10 | 2004-08-18 | 上海华谊生物技术有限公司 | 促胰岛素分泌肽衍生物 |
| US7378385B2 (en) | 2002-08-08 | 2008-05-27 | University Of Cincinnati | Role for GLP-1 to mediate responses to disparate stressors |
| DE102004043153B4 (de) | 2004-09-03 | 2013-11-21 | Philipps-Universität Marburg | Erfindung betreffend GLP-1 und Exendin |
| EA200870575A1 (ru) | 2006-05-26 | 2009-08-28 | Амилин Фармасьютикалз, Инк. | Композиции и способы лечения застойной сердечной недостаточности |
| HRP20220346T3 (hr) | 2007-01-08 | 2022-09-02 | The Trustees Of The University Of Pennsylvania | Antagonist glp-1 receptora za upotrebu u liječenju kongenitalnog hiperinzulinizma |
| EP2310042B1 (en) | 2008-07-08 | 2012-12-05 | Novartis AG | Use of pasireotide for the treatment of endogenous hyperinsulinemic hypoglycemia |
| AU2010258898B8 (en) | 2009-06-08 | 2015-02-05 | Amunix Operating Inc. | Glucose-regulating polypeptides and methods of making and using same |
| US9932381B2 (en) | 2014-06-18 | 2018-04-03 | Sanofi | Exendin-4 derivatives as selective glucagon receptor agonists |
| ES2887723T3 (es) | 2015-05-22 | 2021-12-27 | Univ Leland Stanford Junior | Tratamiento de hipoglucemia posbariátrica con exendina(9-39) |
| BR112019010236A2 (pt) | 2016-11-21 | 2019-08-20 | Eiger Biopharmaceuticals Inc | formulações tamponadas de exendina (9-39) |
-
2008
- 2008-01-08 HR HRP20220346TT patent/HRP20220346T3/hr unknown
- 2008-01-08 EP EP08713063.9A patent/EP2120994B1/en active Active
- 2008-01-08 WO PCT/US2008/000281 patent/WO2008085982A2/en active Application Filing
- 2008-01-08 EP EP22156122.8A patent/EP4049673A1/en active Pending
- 2008-01-08 US US12/522,274 patent/US9821031B2/en active Active
- 2008-01-08 EP EP14171762.9A patent/EP2818181B1/en active Active
- 2008-01-08 HU HUE18201976A patent/HUE058307T2/hu unknown
- 2008-01-08 PL PL18201976.0T patent/PL3456340T3/pl unknown
- 2008-01-08 SI SI200832192T patent/SI3456340T1/sl unknown
- 2008-01-08 ES ES18201976T patent/ES2908838T3/es active Active
- 2008-01-08 TR TR2019/00959T patent/TR201900959T4/tr unknown
- 2008-01-08 EP EP18201976.0A patent/EP3456340B1/en active Active
- 2008-01-08 DK DK18201976.0T patent/DK3456340T3/da active
- 2008-01-08 PT PT182019760T patent/PT3456340T/pt unknown
- 2008-01-08 ES ES14171762T patent/ES2710948T3/es active Active
- 2008-01-08 ES ES08713063.9T patent/ES2499390T3/es active Active
- 2008-01-08 LT LTEP18201976.0T patent/LT3456340T/lt unknown
- 2008-04-10 US US12/081,123 patent/US9616108B2/en active Active
-
2017
- 2017-03-08 US US15/453,823 patent/US10188702B2/en active Active
-
2019
- 2019-01-28 US US16/258,686 patent/US10987407B2/en active Active
-
2020
- 2020-11-25 US US17/105,484 patent/US20210252110A1/en not_active Abandoned
-
2022
- 2022-03-04 CY CY20221100188T patent/CY1125273T1/el unknown
-
2023
- 2023-02-14 US US18/168,570 patent/US20240082361A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US9616108B2 (en) | 2017-04-11 |
| TR201900959T4 (tr) | 2019-02-21 |
| SI3456340T1 (sl) | 2022-08-31 |
| US20100190700A1 (en) | 2010-07-29 |
| EP2818181B1 (en) | 2018-10-24 |
| PT3456340T (pt) | 2022-05-25 |
| ES2499390T3 (es) | 2014-09-29 |
| US20080269130A1 (en) | 2008-10-30 |
| US10188702B2 (en) | 2019-01-29 |
| US20210252110A1 (en) | 2021-08-19 |
| HRP20220346T3 (hr) | 2022-09-02 |
| US20240082361A1 (en) | 2024-03-14 |
| CY1125273T1 (el) | 2023-06-09 |
| US20190336584A1 (en) | 2019-11-07 |
| ES2710948T3 (es) | 2019-04-29 |
| EP4049673A1 (en) | 2022-08-31 |
| ES2908838T3 (es) | 2022-05-04 |
| EP3456340B1 (en) | 2022-02-16 |
| EP2818181A1 (en) | 2014-12-31 |
| EP3456340A1 (en) | 2019-03-20 |
| US10987407B2 (en) | 2021-04-27 |
| PL3456340T3 (pl) | 2022-08-22 |
| EP2120994B1 (en) | 2014-06-11 |
| WO2008085982A3 (en) | 2008-11-20 |
| US9821031B2 (en) | 2017-11-21 |
| EP2120994A2 (en) | 2009-11-25 |
| LT3456340T (lt) | 2022-05-10 |
| WO2008085982A2 (en) | 2008-07-17 |
| HUE058307T2 (hu) | 2022-07-28 |
| US20180050095A1 (en) | 2018-02-22 |
| EP2120994A4 (en) | 2011-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3456340T3 (da) | Glp-1-receptorantagonist til brug ved behandling af medfødt hyperinsulisme | |
| ATE509022T1 (de) | Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide | |
| DK2129654T3 (da) | Antagonister af glucagonreceptoren | |
| FR2924330B1 (fr) | Implant pour hernie parastomiale | |
| DK3222277T3 (da) | Biphenylsulfonamidendothelin- og angiotensin II-receptorantagonist til behandling af glomerulosklerose og IgA-induceret nefropati | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| DK2220076T3 (da) | Inhibitorer af replikationen af humant immundefektvirus | |
| DK1729753T3 (da) | Anvendelse af en NMDA-receptor-antagonist til behandling af tinnitus induceret ved kokleær excitotoksicitet | |
| ATE481405T1 (de) | Thiazolpyrazolopyrimidine als antagonisten des crf1-rezeptors | |
| DK2061485T3 (da) | EV576-peptider til anvendelse ved behandling af Guillain-Barré-syndrom | |
| DK3219815T3 (da) | Fremgangsmåder og sammensætninger til at fremstille squalen under anvendelse af gær | |
| FI20070924A0 (fi) | Hissin valmiustila | |
| FI7098U1 (fi) | Kaidejärjestelmä | |
| DK2200600T3 (da) | Neramexan til anvendelse ved behandlingen af subakut tinnitus | |
| DK2124946T3 (da) | Anvendelse af N-methylpyridiniumderivater til hepatobeskyttelse | |
| DE112008002921A5 (de) | Bohrfutter | |
| ZA200808766B (en) | Nitrated heterocyclic compounds as endothelin receptor antagonist | |
| DK1856035T3 (da) | Fremgangsmåde til fremstilling af beskyttelse amidiner | |
| DK2121138T3 (da) | Terapeutiske anvendelser af eslicarbazepin | |
| DK2120919T3 (da) | Ny kombination til anvendelse ved behandling af inflammatoriske lidelser | |
| ITRA20060017U1 (it) | Gruppo erogatore per lavelli | |
| DK2621517T4 (da) | Sammensætning til anvendelse i behandlingen af infertilitet | |
| DK2001499T3 (da) | Anvendelse af TGS-6 til behandling af osteoporose | |
| DK1992352T3 (da) | Middel til anvendelse i forbyggelsen af aterosklerosis | |
| DK2229943T3 (da) | Forbindelse til anvendelse ved behandling af perifer neuropati |